Changrui Xiao

Changrui Xiao

Auto-generated profile, based on publicly available information

Changrui Xiao

University of California, Irvine, Institute for Clinical and Translational Science

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Neuron
Verified
Journal Article
Closed access
JRJoseph E. Rittiner
Joseph E. Rittiner
ZCZachary F. Caffall
Zachary F. Caffall
RHRicardo Hernández-Martinez
Ricardo Hernández-Martinez
SSSydney M. Sanderson
Sydney M. Sanderson
JPJames L. Pearson
James L. Pearson
NCNicole Calakos
Nicole Calakos

1 October 2019 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
CXChangrui Xiao
Changrui Xiao
EBElaine M. Binkley
Elaine M. Binkley
JRJessica Rexach
Jessica Rexach
AKAmy Knight-Johnson
Amy Knight-Johnson
PKPravin Khemani
Pravin Khemani
CGChristopher M. Gomez
Christopher M. Gomez
Objective To identify the genetic cause of autosomal dominant spinocerebellar ataxia and retinitis pigmentosa in a large extended pedigree. Methods Clinical studies were done at 4 referral centers. Ten individuals in the same extended family participated in at least a portion of the study. Records were obtained from an 11th, deceased, individual. Neurologic and dermatological examinations were performed. Ophthalmologic evaluation including funduscopic examination and in some cases ocular coherence tomography were used to identify the presence of retinal disease. Whole exome sequencing (WES), in conjunction with Sanger sequencing and segregation analysis, was used to identify potential genetic mutation. Results Affected individuals reported slowly progressive cerebellar ataxia with age at onset between 38 and 57. Imaging demonstrated cerebellar atrophy (3/3). WES identified a novel heterozygous mutation in the elongation of very long chain fatty acids 4 (ELOVL4) gene (c.512T>C, p.Ile171Thr) that segregated with ataxia in 7 members tested. Four of 8 members who underwent ophthalmologic evaluation were found to have retinitis pigmentosa. No skin findings were identified or reported. Ocular movement abnormalities and pyramidal tract signs were also present with incomplete penetrance. Conclusions We report a family with both spinocerebellar ataxia and retinal dystrophy associated with an ELOVL4 mutation. In addition, to supporting prior reports that ELOVL4 mutations can cause spinocerebellar ataxia, our findings further broaden the spectrum of clinical presentations associated with spinocerebellar ataxia 34.

16 February 2021 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
CXChangrui Xiao
Changrui Xiao
FRFrancis Rossignol
Francis Rossignol
FVFrédéric M. Vaz
Frédéric M. Vaz
CFCarlos R. Ferreira
Carlos R. Ferreira

17 August 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
CXChangrui Xiao
Changrui Xiao
EAEsteban Astiazaran‐Symonds
Esteban Astiazaran‐Symonds
SBShrabani Basu
Shrabani Basu
MKMonisha Kisling
Monisha Kisling
FSFernando Scaglia
Fernando Scaglia
CFCarlos R. Ferreira
Carlos R. Ferreira

8 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
YCYuyang Chen
Yuyang Chen
RDRuebena Dawes
Ruebena Dawes
HKHyung Chul Kim
Hyung Chul Kim
SSSarah L Stenton
Sarah L Stenton
SWSusan Walker
Susan Walker
NWNicola Whiffin
Nicola Whiffin
Around 60% of individuals with neurodevelopmental disorders (NDD) remain undiagnosed after comprehensive genetic testing, primarily of protein-coding genes 1 . Increasingly, large genome-sequenced cohorts are improving our ability to discover new diagnoses in the non-coding genome. Here, we identify the non-coding RNA RNU4-2 as a novel syndromic NDD gene. RNU4-2 encodes the U4 small nuclear RNA (snRNA), which is a critical component of the U4/U6.U5 tri-snRNP complex of the major spliceosome 2 . We identify an 18 bp region of RNU4-2 mapping to two structural elements in the U4/U6 snRNA duplex (the T-loop and Stem III) that is severely depleted of variation in the general population, but in which we identify heterozygous variants in 119 individuals with NDD. The vast majority of individuals (77.3%) have the same highly recurrent single base-pair insertion (n.64_65insT). We estimate that variants in this region explain 0.41% of individuals with NDD. We demonstrate that RNU4-2 is highly expressed in the developing human brain, in contrast to its contiguous counterpart RNU4-1 and other U4 homologs, supporting RNU4-2 ’s role as the primary U4 transcript in the brain. Overall, this work underscores the importance of non-coding genes in rare disorders. It will provide a diagnosis to thousands of individuals with NDD worldwide and pave the way for the development of effective treatments for these individuals.

18 July 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
CXChangrui Xiao
Changrui Xiao
MKMary Koziura
Mary Koziura
HCHeidi Cope
Heidi Cope
RSRebecca Spillman
Rebecca Spillman
KTKhoon Tan
Khoon Tan
CTCamilo Toro
Camilo Toro
Objectives: To review the referral and clinical characteristics of adult patients diagnosed with lysosomal storage diseases (LSD) through the Undiagnosed Diseases Network (UDN).Methods: Retrospective review of both application and evaluation records for adults admitted to the UDN with a final diagnosis of a lysosomal storage disease.Results: Ten patients were identified. Final diagnoses included late onset Tay Sachs, attenuated MPS I, MPS IIIA, MPS IIIB, and MPS IIIC. Most patients presented with neurocognitive changes. Prior to referral, all patients had been evaluated by neurology, four patients underwent phenotype specific panel testing that did not include the causative gene, and four patients had non‐diagnostic clinical exome sequencing.Conclusions: LSDs figure highly in the differential diagnosis of neurometabolic disorders in pediatric onset progressive diseases. In adults, their subtle initial presentations overlap with symptoms of more common disorders and less practitioner awareness may lead to prolonged diagnostic challenges.